Evaluation of the VITEK2 BCL card for identification of Bacillus species and other aerobic endosporeformers

Letters in Applied Microbiology
G HalketN A Logan

Abstract

To evaluate the performance of the VITEK2 Bacillus identification card (BCL) for the identification of aerobic endospore-forming bacteria, using fresh isolates and reference strains. One hundred and nine industrial, environmental and clinical isolates were tested using the BCL card. The card contained 46 substrates for measuring carbon source utilization, enzymatic activities, inhibition by 6.5% NaCl and resistance to the antibiotics kanamycin, oleandomycin and polymyxin B. Identifications were made after 14 h incubation, using a database allowing identification of 42 species of the genera Aneurinibacillus, Bacillus, Brevibacillus, Geobacillus, Paenibacillus and Virgibacillus. The reference identities of all isolates were authenticated by phenotypic methods, with 16S rRNA gene sequencing used to resolve discrepancies. One hundred and one strains (93%) were identified correctly to species level, seven strains (6%) were incorrectly identified, and one strain (1%) remained unidentified. The VITEK2 BCL card provides a major advance in the reliable identification of Bacillus species and members of related genera.

References

Jul 1, 1992·Clinical Microbiology Reviews·C E Stager, J R Davis
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Jul 1, 1988·Journal of General Microbiology·F G PriestC Todd
Jul 1, 1984·Journal of General Microbiology·N A Logan, R C Berkeley
Aug 9, 2007·International Journal of Systematic and Evolutionary Microbiology·Sun-Young AnAkira Yokota
Jul 2, 2009·International Journal of Systematic and Evolutionary Microbiology·N A LoganA Ventosa

❮ Previous
Next ❯

Citations

Nov 7, 2015·Scientific Reports·Riccardo RosselliPietro Cappuccinelli
Dec 25, 2019·Journal of Infection and Public Health·Mohamed N AlanberJamal M Khaled

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.